Cempra Announces The Completion Of Phase 1 Studies For CEM-101, A Next-Generation Macrolide

Links shared publicly online about this topic.

  • 1,322
    total visits

Cempra Announces The Completion Of Phase 1 Studies For CEM-101, A Next-Generation Macrolide

medicalnewstoday.com —

Cempra Pharmaceuticals announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announce

View full resource at medicalnewstoday.com

Tags: Asthma, Pharma, Phase 1 Clinical Trial, Clinical Trial

  • Share

Most Recently Shared on March 11, 2010 at 8:09 pm By:

mnt_clinical MNT Clinical Trials

Cempra Announces The Completion Of Phase 1 Studies For CEM-101, A Next-Generation Macrolide http://mnt.to/3yMj #clinicaltrials

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Asthma News MNT Asthma News

MNT Pharma News MNT Pharma News

Advertisement